Jennewein Biotechnologie GmbH is a leading company specializing in the production of rare functional monosaccharides and oligosaccharides for nutritional, pharmaceutical, cosmetic and medical applications. The company produces rare monosaccharides such as L-Fucose and Sialic Acid. It also manufactures an extensive portfolio of HMO’s such as 2‘-Fucosyllactose, 3‘-Fucosyllactose, Lacto-N-tetraose, Lacto-N-neotetraose and acidic HMO’s like 3‘-Sialyllactose and 6‘-Sialyllactose. Jennewein’s human milk oligosaccharides are produced using the latest fermentation technology.
This manufacturing process is based on scientific research and ensures a high quality and safety of the product; the oligosaccharides produced in that way are structurally and functionally identical to natural HMO’s.
The process can be conducted at reasonable production cost, so that for the first time an HMO can be synthesized in such large amounts that it can be used as supplement in infant food and other food products as for example medical nutrition products or food supplements.Other possible applications are in milk drinks, juices or cereal bars. In the field of R&D the company cooperates with leading German universities and research institutes. Jennewein received in 2015 approval in the US (GRAS) and in 2017 the novel food authorization for 2‘-Fucosyllactose in the European Union.
The HMO‘s produced by Jennewein are approved for kosher and halal.The product is marketed under the brand-name Mum’s Sweet Secret.